Fundraising Fox

Areteia Therapeutics

Chapel Hill, US · Founded 2022 · Delaware corporation · 3 known investors

areteiatx.com ↗

Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.

Biotech

Founders & leadership

RW
Robin WalkerExecutive Officer
CC
Christopher CourtsExecutive Officer
JB
Jorge BartolomeExecutive Officer, Director
BG
Benjamin GomezDirector
AK
Adam KoppelDirector
ME
Michael E. BozikDirector
DB
Daniel BeckerDirector
PB
Paul BernsDirector
SB
Stephen ButtsDirector
ES
Elyse StockDirector
IR
Ian ReadDirector

Investors · 3

ARCH Venture PartnersChicago · $50K – $250M
Bain Capital Life SciencesBostonvia Adam M. Koppel · board
GV (Google Ventures)Mountain View · $250K – $50M

Reported raises · per SEC filings

Form D private placements
▶$360MraisedFeb 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin GomezDirector
  • Adam KoppelDirector
  • Ian ReadDirector
  • Michael E. BozikDirector
  • Daniel BeckerDirector
  • Robin WalkerExecutive Officer
  • Paul BernsDirector
  • Christopher CourtsExecutive Officer
  • Stephen ButtsDirector
  • Jorge BartolomeExecutive Officer, Director
  • Elyse StockDirector
Offering amount
$445M
Amount sold
$360M
Sales commissions
$13M
Placement agents
COWEN AND COMPANY, LLC
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news